DNB Carnegie Investment Bank AB

SciBase Recalculates TO 2 Warrant Terms After September Rights Issue

Stockholm – October 07, 2026 -- SciBase Holding AB has recalculated the terms of its series TO 2 warrants following a rights issue of shares resolved by its board on September 3, 2026, cutting the subscription ratio to 0.01 shares per warrant.

Subscription price drops to SEK 37.47 per share under new warrant terms

Each TO 2 warrant now entitles the holder to subscribe for 0.01 new shares at SEK 37.47 per share, down from the original terms set when the instrument was issued alongside SciBase's April 2024 capital raise. The adjustment follows contractual provisions requiring recalculation of warrant terms whenever the company conducts a subsequent rights issue.

SciBase Delays Rights Issue Trading Start by One Day to Sept 16

Stockholm – September 18, 2026 -- SciBase Holding AB has pushed back the first day of trading in subscription rights and paid subscribed shares (BTA) tied to its ongoing rights issue by one day, moving the start date from September 18, 2026 to September 18, 2026 on Nasdaq First North Growth Market.

The subscription period itself remains unchanged, running from September 15 through September 18, 2026.

Timetable shift leaves subscription window intact

The Swedish medtech company confirmed the updated timetable applies only to the trading commencement of subscription rights and BTAs, not to the underlying subscription mechanics of the capital raise.

Michael Colérus, Chief Financial Officer of SciBase, is the designated contact for investor inquiries related to the adjustment.